Tomoya Maeda
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
-
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 28
- Acute Myeloid Leukemia Research 15
- Chronic Myeloid Leukemia Treatments 9
- Hematopoietic Stem Cell Transplantation 5
- Genetics 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Chronic Lymphocytic Leukemia Research 5
- Co-authors
- Maho Ishikawa (18 shared papers)Masami Bessho (11 shared papers)Fumiharu Yagasaki (5 shared papers)Yasushi Miyazaki (10 shared papers)Shigeki Ohtake (10 shared papers)Yoshihiro Hatta (8 shared papers)Norio Asou (17 shared papers)Seiji Ueda (1 shared paper)
- Journals
- International Journal of Hematology (4 papers)Blood (3 papers)Annals of Hematology (3 papers)Journal of Clinical and Experimental Hematopathology (3 papers)Leukemia Research (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Tomoya Maeda
38 papers receiving 405 citations
Peers
Comparison fields: 5 of 73
- Hematology 202
- Genetics 53
- Oncology 126
- Public Health, Environmental and Occupational Health 105
- Emergency Medicine 24
Countries citing papers authored by Tomoya Maeda
This map shows the geographic impact of Tomoya Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Maeda more than expected).
Fields of papers citing papers by Tomoya Maeda
This network shows the impact of papers produced by Tomoya Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Maeda. The network helps show where Tomoya Maeda may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomoya Maeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 53 | |
| 2 | 2013 | 35 | |
| 3 | 2020 | 34 | |
| 4 | 2018 | 29 | |
| 5 | 2004 | 23 | |
| 6 | 2012 | 22 | |
| 7 | 2017 | 21 | |
| 8 | 2017 | 20 | |
| 9 | 2007 | 19 | |
| 10 | 2007 | 17 | |
| 11 | 2020 | 15 | |
| 12 | 2012 | 15 | |
| 13 | 2001 | 14 | |
| 14 | 2015 | 12 | |
| 15 | 1991 | 11 | |
| 16 | 2014 | 10 | |
| 17 | 2013 | 9 | |
| 18 | 2020 | 9 | |
| 19 | 2024 | 6 | |
| 20 | 2000 | 3 |
About Tomoya Maeda
Tomoya Maeda is a scholar working on Hematology, Genetics, Molecular Biology, Public Health, Environmental and Occupational Health and Oncology, having authored 44 papers that have together received 409 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Chronic Myeloid Leukemia Treatments (9 papers), Acute Lymphoblastic Leukemia research (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Eosinophilic Disorders and Syndromes (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Hematology (202 citations), Genetics (53 citations), Oncology (126 citations), Public Health, Environmental and Occupational Health (105 citations) and Emergency Medicine (24 citations). Tomoya Maeda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Maho Ishikawa, Masami Bessho, Fumiharu Yagasaki, Yasushi Miyazaki, Shigeki Ohtake, Yoshihiro Hatta, Norio Asou, Seiji Ueda, Itsuro Jinnai and T Masaoka. Their work appears in journals such as International Journal of Hematology, Blood, Annals of Hematology, Journal of Clinical and Experimental Hematopathology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.